ADARC is a not-for-profit AIDS (and lately Covid-19) research center located in New York. ADARC, as well as other not-for-profit organizations, have a common end goal of complete curing of the AIDS disease. Is GlaxoSmithKline's (GSK) approach comparible in selling its HIV drugs at cost to some 60 countries around the world, to the not-for-profit's goal of complete curing of the disease? Do they have the same goals? What can happen to GSK and what can happen to the not-for-profit if their expenses exceed their revenues? ADARC is a not-for-profit AIDS (and lately Covid-19) research center located in New York. ADARC, as well as other not-for-profit organizations, have a common end goal of complete curing of the AIDS disease. Is GlaxoSmithKline's (GSK) approach comparible in selling its HIV drugs at cost to some 60 countries around the world, to the not-for-profit's goal of complete curing of the disease? Do they have the same goals? What can happen to GSK and what can happen to the not-for-profit if their expenses exceed their revenues